Does TREPROSTINIL Cause Bronchopulmonary dysplasia? 14 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 14 reports of Bronchopulmonary dysplasia have been filed in association with TREPROSTINIL (TYVASO). This represents 0.0% of all adverse event reports for TREPROSTINIL.
14
Reports of Bronchopulmonary dysplasia with TREPROSTINIL
0.0%
of all TREPROSTINIL reports
9
Deaths
5
Hospitalizations
How Dangerous Is Bronchopulmonary dysplasia From TREPROSTINIL?
Of the 14 reports, 9 (64.3%) resulted in death, 5 (35.7%) required hospitalization, and 2 (14.3%) were considered life-threatening.
Is Bronchopulmonary dysplasia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TREPROSTINIL. However, 14 reports have been filed with the FAERS database.
What Other Side Effects Does TREPROSTINIL Cause?
Dyspnoea (16,348)
Headache (14,051)
Diarrhoea (11,335)
Nausea (10,320)
Cough (8,945)
Fatigue (7,440)
Dizziness (7,405)
Infusion site pain (5,169)
Vomiting (5,097)
Death (4,764)
What Other Drugs Cause Bronchopulmonary dysplasia?
IBUPROFEN (41)
PALIVIZUMAB (39)
ONDANSETRON (29)
MORPHINE (24)
BETAMETHASONE (22)
MAGNESIUM (22)
BOSENTAN (19)
INDOMETHACIN (19)
ACETAMINOPHEN (18)
ALBUTEROL (18)
Which TREPROSTINIL Alternatives Have Lower Bronchopulmonary dysplasia Risk?
TREPROSTINIL vs TREPROSTINIL DIOLAMINE
TREPROSTINIL vs TRETINOIN
TREPROSTINIL vs TRIAMCINOLONE
TREPROSTINIL vs TRIAMCINOLONE ACETONIDE
TREPROSTINIL vs TRIAMCINOLONE HEXACETONIDE